beyondMD operates as a telehealth-focused peptide therapy and metabolic health clinic serving patients throughout San Francisco, CA and beyond. The clinic specializes in personalized peptide-based protocols designed to address weight management, metabolic dysfunction, and longevity optimization through remote consultations and at-home treatment delivery. With board certification in Emergency Medicine and certification by the American Academy of Nurse Practitioners, the clinical team brings acute care expertise to the functional medicine space, enabling rapid assessment and evidence-based treatment planning for patients seeking alternatives to traditional weight loss and wellness approaches.
The clinic's peptide offerings center on three primary therapeutic agents: Semaglutide and Tirzepatide for metabolic health and weight management, and PT-141 for sexual wellness applications. Semaglutide, a GLP-1 receptor agonist, is prescribed as part of comprehensive weight loss programs that include metabolic monitoring and lifestyle modification support. Tirzepatide, a dual GIP/GLP-1 receptor agonist, represents the clinic's advanced option for patients requiring more robust glycemic control or enhanced weight reduction outcomes. PT-141 (bremelanotide) is offered for patients experiencing sexual dysfunction, working through melanocortin receptor pathways rather than vascular mechanisms. Each peptide protocol is individualized based on patient health history, current medications, metabolic markers, and specific wellness goals, with dosing titrated according to response and tolerance.
The clinical approach at beyondMD combines emergency medicine diagnostic skills with functional medicine principles, allowing providers to identify contraindications, manage side effects, and adjust protocols based on patient feedback during virtual follow-ups. Initial consultations involve comprehensive health assessments including review of recent laboratory work, medication reconciliation, and discussion of realistic treatment timelines. The American Academy of Nurse Practitioners certification ensures that nurse practitioners on the team maintain advanced practice standards for prescribing and patient management. This dual certification background enables the clinic to handle both the prescriptive aspects of peptide therapy and the urgent troubleshooting that occasionally arises with GLP-1 therapies, such as managing gastrointestinal side effects or adjusting dosing during illness.
Patients engage with beyondMD entirely through telehealth platforms, eliminating the need for in-person visits to a San Francisco clinic location. After the initial video consultation, peptide medications are shipped directly to patient homes with detailed administration instructions, typically via subcutaneous injection. Follow-up appointments are scheduled at regular intervals—usually every four to six weeks during active treatment—to assess progress, review any side effects, and modify treatment plans as needed. The clinic provides ongoing access to clinical staff for questions between scheduled appointments, and patients are expected to obtain periodic laboratory testing through local facilities to monitor metabolic markers, kidney function, and other relevant parameters during Semaglutide or Tirzepatide therapy. This model appeals particularly to San Francisco-area professionals and residents who prefer the convenience of remote care without sacrificing clinical oversight.
What distinguishes beyondMD in the competitive telehealth peptide space is the emergency medicine foundation of its clinical team, which translates to heightened vigilance around patient safety, drug interactions, and contraindications that may be overlooked in less medically rigorous wellness programs. The clinic's focus remains narrow—peptide therapy for metabolic health, longevity, and sexual wellness—rather than attempting to cover the full spectrum of functional medicine services. This specialization allows for deeper expertise in the specific peptides offered and more refined protocols based on patient outcomes. The at-home delivery model, combined with the telehealth consultation structure, makes peptide therapy accessible to patients across California who may not have local access to providers experienced in these newer therapeutic agents, while the San Francisco base positions the clinic within a market that values both technological convenience and evidence-based medical innovation.
John Marley Bernard Jr., MD
Nurse Director
John Bernard, MD graduated from Jefferson Medical College with an MD degree and completed an emergency medicine residency at the State University of New York at Buffalo. He is board certified in Emergency Medicine and has practiced in a variety of emergency departments as well as urgent care and telemedicine settings over the last 20 years.
Hollie Ann Hall, APRN-C
Advanced Practice Registered Nurse
Hollie Ann Hall, APRN-C, graduated from Baker University in 2003 as a registered nurse with a Bachelor of Science in Nursing. Hollie received her degree as a Family Nurse Practitioner from the University of Phoenix in 2010 and is certified by the American Academy of Nurse Practitioners. She enjoys spending time with her family and can be found cheering at her children’s sporting events.
Jordan Dorsey, NP
Nurse Practitioner
Jordan Dorsey, NP, is a compassionate nurse practitioner with expertise in endocrinology, primary care, dermatology, and urology. Jordan specializes in treating erectile and sexual dysfunction, hair loss, libido concerns, and hormone imbalances. Known for creating a supportive environment, Jordan educates and empowers patients to take charge of their health.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.
San Francisco, CA
